Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflammation and remodeling in mice.
Experimental mouse models of asthma have broadened our understanding of the mechanisms behind allergen-induced asthma. Typically, mouse models of allergic asthma explore responses to a single allergen; however, patients with asthma are frequently exposed to, and tend to be allergic to, more than one allergen. The aim of the current study was to develop a new and more relevant mouse model of asthma by measuring the functional, inflammatory and structural consequences of chronic exposure to a combination of two different allergens, ovalbumin (OVA) and house dust mite (HDM), in comparison with either allergen alone. BALB/c mice were sensitized and exposed to OVA, HDM or the combination of HDM and OVA for a period of 10 weeks. Following allergen exposure, airway responsiveness was measured using the flexiVent small animal ventilator, and mice were assessed for indices of airway inflammation and remodeling at both 24 hours and 4 weeks after the final allergen exposure. Mice exposed to the HDM-OVA combination exhibited increased numbers of inflammatory cells in the bronchoalveolar lavage (BAL) when compared with mice exposed to a single allergen. Mice exposed to HDM-OVA also exhibited an elevated level of lung tissue mast cells compared with mice exposed to a single allergen. Following the resolution of inflammatory events, mice exposed to the allergen combination displayed an elevation in the maximal degree of total respiratory resistance (Max R(RS)) compared with mice exposed to a single allergen. Furthermore, trends for increases in indices of airway remodeling were observed in mice exposed to the allergen combination compared with a single allergen. Although concurrent exposure to HDM and OVA resulted in increased aspects of airway hyperresponsiveness, airway inflammation and airway remodeling when compared with exposure to each allergen alone, concurrent exposure did not result in a substantially more robust mouse model of allergic asthma than exposure to either allergen alone.
DiGiovanni
Franco A
FA
Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada.
Ellis
Russ
R
Wattie
Jennifer
J
Hirota
Jeremy A
JA
Southam
David S
DS
Inman
Mark D
MD
D000485:Allergens / Q000008:administration & dosage* / Q000276:immunology*; D000818:Animals; D016535:Bronchial Hyperreactivity / Q000150:complications* / Q000276:immunology* / Q000503:physiopathology; D018893:Bronchoalveolar Lavage; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002452:Cell Count; D020397:Goblet Cells / Q000276:immunology / Q000473:pathology; D007249:Inflammation / Q000150:complications* / Q000276:immunology* / Q000503:physiopathology; D019570:Inhalation Exposure; D015847:Interleukin-4 / Q000378:metabolism; D008407:Mast Cells / Q000276:immunology / Q000473:pathology; D051379:Mice; D009119:Muscle Contraction; D010047:Ovalbumin / Q000276:immunology; D039981:Pyroglyphidae / Q000276:immunology; D012965:Sodium Chloride; D013154:Spleen / Q000166:cytology / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D000485:Allergens; D015847:Interleukin-4; D012965:Sodium Chloride; D010047:Ovalbumin